Kyokuto Securities

Kyokuto Pharmaceutical Industrial Co., Ltd. is a prominent Japanese biotechnology company specializing in the development and manufacture of clinical diagnostic reagents and specialized culture media. Founded in 1933, the company has established a leading position in clinical microbiology, providing essential tools for bacterial identification, drug susceptibility testing, and immunodiagnostics. Kyokuto is particularly recognized for its high-quality cell culture media, including serum-free formulations for human iPS and ES cells, which support the fields of regenerative medicine and drug discovery. The company operates a major manufacturing and research center in Takahagi, Ibaraki, and maintains a robust distribution network across Japan and internationally. Through its expertise in microbiology and cell biology, Kyokuto continues to innovate in the areas of infectious disease testing and advanced therapeutic research tools.